Peter Lando and Robert Lichter authored “Design Patents Overlooked in Many IP Portfolios,” published in the Fall 2018 issue of Today’s General Counsel.

Keith Noe and Peter Lando authored “Too Much Confidence in Your Confidentiality Agreements-Concern over the Commoditization of NDAs,” published by Corporate Counsel, September 28, 2018.

Gregory Gerstenzang‘s article, “A Primer on Blockchain and Cryptocurrencies” was published in Massachusetts Lawyers Weekly, Vol. 47, Issue 24, June 2018.

Craig R. Smith recently published an article in the Fall 2017 Issue of Today’s General Counsel, “Protecting Client Data When Traveling“

Craig R. Smith was quoted in a Massachusetts Lawyers Weekly article Estate planning work doesn’t trigger firm disqualification: Attorney-client relationship ended when task completed, published on October 16, 2017

Craig R. Smith recently published an article in the Journal of Commercial Biotechnology, “A Biotechnology Dilemma: Patent Your Inventions (if you can) or Keep Them Secret”

Peter C. Lando and David Andreasen’s article, “Inventorship – What you Need to Know to Avoid Problems“, published in the September 2017 issue of IEEE’s The Reflector

Peter C. Lando and Thomas P. McNulty’s article, “Provisional Patent Rights – An Underutilized Protection“, published in the July/August issue of Today’s General Counsel magazine

Craig R. Smith’s article, “Trump’s Hiring Freeze Could Hurt Tech Sector“, published on June 9, 2017 [Note: Subscription required to read full article.]

Craig R. Smith was quoted in a Washington Post article “How can you protect your right to digital privacy at the border?“, published on June 8, 2017.

Limitations on Enforceability of Patent Rights

“Cooking with Alice: A Recipe for Responding to § 101 ‘Abstract Idea’ Rejections”, Gregory K. Gerstenzang, November 9, 2015.

Community-of-interest privilege bars discovery of email exchange

Does the Doctrine of Inequitable Conduct Still Have Life After Theranese?

(R)evolution in Design Patent Subject Matter

Biosimilarity and Interchangeability in the Biologics Price Competition and Innovation Act of 2009 and FDA’s 2012 Draft Guidance for Industry

Costs of Patent Reexaminations May Skyrocket

A World of Copyright Confusion on the Web